Hapoalim Securities initiates coverage on BioSpecifics (Nasdaq: BSTC) with a Market Outperform. Price target $40.

Hapoalim analyst says, "In our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE